Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Quantum Corporation (QMCO) Q2 2027 Earnings Call Transcript
Quantinuum and RIKEN Expand Partnership to Accelerate the Commercialization of Quantum-AI Hybrid Supercomputing in Japan
What Quantum (QMCO) Said on Its Q2 Earnings Call
ROSEN, LEADING TRIAL ATTORNEYS, Encourages D-Wave Quantum Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – QBTS
Quantum Corp. (QMCO) Q2 Earnings and Revenues Surpass Estimates
Quantum Computing Inc. Reports Third Quarter 2026 Financial Results
Quantum Reports Fiscal Second Quarter 2027 Financial Results
Deadline Alert: D-Wave Quantum, Inc. Investors Have Until December 15, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors
QNT Q3 Earnings Call Highlights Raised Outlook and Quantum Progress
D-Wave and Rigetti Face High Stakes After Quantum Peers Raise the Earnings Bar
Quantum X Labs Expands AI-Powered Quantum Error Correction Program to Three IBM Quantum Processors, Demonstrating Up to 20% Fewer Logical Decoding Failures
Rail Vision's Quantum Platform Launches End-to-End Quantum Error Correction Program at the Israeli Quantum Computing Center
ROSEN, SKILLED TRIAL ATTORNEYS, Encourages D-Wave Quantum Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QBTS
3 Millionaire-Maker Quantum Computing Stocks
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages D-Wave Quantum Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QBTS
ROSEN, SKILLED INVESTOR COUNSEL, Encourages D-Wave Quantum Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QBTS
D-Wave Quantum Earnings Preview: Real Customers, But Bull Case Still Priced In
Quantum-Si Q3 Earnings Call Highlights
Pomerantz Law Firm Announces the Filing of a Class Action Against D-Wave Quantum Inc. and Certain Officers - QBTS
Quantum BioPharma Ltd. Announces Filing of Supplement to Management Information Circular Correcting Fractional Share Treatment Under Proposed Share Consolidation and Clarifies MVS Voting Power Threshold